EUROIMMUN AG, founded in Germany in 1987, markets its products in 130 European, North American, South American, Asian, and African countries and Australia. The company is famous for its unique patented TITERPLANE® technology which it successfully uses in indirect immunosorbent IIFT и EUROArray methods.
Being a reputed world producer, the company has its own research institute, independent reference laboratory, and Training Academy. In April 2014, the WirtschaftsWoche magazine rated the company 3rd best innovator among German medium-sized enterprises.
EUROIMMUN offers a considerable portfolio of lab tests for diagnosing almost all known autoimmune and allergic diseases, a wide spectrum of infectious and hereditary pathologies, Alzheimer’s disease, indicators of bone turnover, stress, kidney functions, and gluten intolerance.
The equipment and reagents produced by the company use the following methods:
— Solid-phase enzyme-linked immunosorbent assay (ELISA)
— Indirect immunosorbent test (IIFT)
— Blotting (BLOT)
— Chemoluminescent immunological assay (ChLIA)
— Multi-result genetic diagnostics (EUROArray)
Tested human materials are blood, urine, spinal fluid, saliva, feces.
The wide range of equipment allows for forming an exploratory line for tests in any volumes. Small laboratories can use test systems in manual mode. For medium-sized laboratories there are semiautomatic systems and small automatic ones. Maximum capacity laboratory systems are available for large laboratories. Machines preclude any human error and provide standard conditions for obtaining test results.
All Euroimmun AG equipment is provided with warranty and post-warranty service.
The Spanish company VitAssay offers non-invasive express tests for early diagnostics of various pathogens based on the technology of immune chromatography with latex microspheres. Tests use samples of feces, urine, or respiratory scrape. Accurate results are available in 10 minutes.
VitAssay express tests detect a wide range of viruses:
noroviruses, rotaviruses, adenoviruses, astroviruses, hepatitis viruses, enteroviruses, respiratory viruses, influenza A viruses;
bacteria:
salmonella, clostridium difficile, campylobacter, coliform bacteria, helicobacter pylori, enterobacteria, streptococci, legionella;
and parasites:
amoebae, lamblia, cryptosporidium;
also:
feces occult blood for early detection of the tumor process and inflammatory bowel disease.
ImmunodiagnosticSystems (IDS) specializes in manufacture of diagnostic systems for endocrinological assays. On the lab diagnostics market the company offers a unique complete panel for bone tissue examination.
IDS tests ensure early detection of osteoporosis (especially in aged persons and those belonging to clinical, genetic, or medicamentous risk groups) and prescription of the most effective therapy.
Precise quantification of the level of resorption or bone tissue formation enables effective control of treatment and prognostication of the patient’s further condition.
On the lab research market the Canadian company GenomeMe offers a range of products for immune chemo-histological cancer diagnostics.
The GeneAb antibody reagents ensure the highest veracity in detecting and differentiating cancer-specific markers of carcinomas, lymphomas, melanomas and various types of leucosis as well as liver, kidney, breast, lung, ovary, cervical, bladder, intestine, stomach, soft tissue, pancreas, brain, prostate, and thyroid gland tumors, neoplasms of neuroendocrine origin, and bone diseases.
Diametra produces immune diagnostic test kits for detecting autoimmune, rheumatic and endocrinal disorders, monitor diabetes treatment, and help to diagnose cancer.
Using the products presented in the company’s catalog it is possible to diagnose various types of vasculitis, gastroenterological and rheumatic diseases, thromboses, and thyroid pathologies with very high probability.
The reagent test portfolio includes
— Hormone and steroid tests
— Autoantibody enumeration tests
— Tumor marker tests
— Reproductive hormone tests
— Circulating immune complex tests
BioMaxima S.A. has firm positions on the microbiological lab market. The company’s internationally certified products are used in clinical medicine, sanitary laboratories, cosmetology, and control over pharmaceutical and food production.
The BioMaxima catalog offers:
— Reagents for general blood and urine tests;
— Express tests for detecting infectious diseases, tumor and myocardial infarction markers and drug addiction signs;
— Ready microbiological media in Petri and Rodak dishes, tubes and flasks;
— Ready dehydrated (dry) fast breeding media;
— Selective additives to nutritive media;
— Antibiotic disks.
The German company Immundiagnostik AG, established in 1986, sells its products in more than 70 countries.
The range of lab reagents and tests covers the entire spectrum of instruments for identifying risks of atherosclerosis, hypertension, diabetes, infertility, Alzheimer’s, and other diseases as well as for differential diagnostics and therapeutic medication control. This primarily concerns cardiovascular, nephric and gastroenterological diseases, bone pathologies, and ageing process control.
The Immundiagnostik AG catalog lists innovative biochemical and radioimmune assays (ELISA, RIA), various analytical lab assay methods (high-yield liquid chromatography, liquid chromatography and tandem mass spectrometry), a wide range of antibodies and antigens, polymerase chain reaction (PCR), and materials for photometric assays.
Tinyteria was founded in 2010.
In 2011 a subsidiary company Tinyteria Ukraine was set up in order to work in the Ukrainian market.
2012-2014 development of direct and sub-disributor network in Georgia, Armenia, Moldova market.
In 2015 a company Sudel was founded in the Belarus market.
Since the end of 2017 we have been working with Baltic countries (Lithuania, Latvia, Estonia).
Group company Tubuva UAB was founded in 2018.